ММВБ 3 146 0,2%  Nasdaq 9 315 -0,9%  Биткойн 8 635 0,4%  USD/RUB 62,2336 0,2% 
РТС 1 600 0,2%  S&P500 3 295 -0,9%  Нефть 59,3 -2,0%  EUR/RUB 68,1645 -0,5% 
Dow 28 990 -0,6%  FTSE100 7 586 1,0%  EUR/USD 1,1029 0,0% 

Курс акций Ultragenyx Pharmaceutical [ISIN: US90400D1081]

купить
продать

Ultragenyx Pharmaceutical Inc - Профиль

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development and commercialization of novel products for the treatment of serious rare and ultra-rare genetic diseases. Its product includes Mepsevii and Crysvita. The company was founded by Emil D. Kakkis on April 22, 2010 and is headquartered in Novato, CA.

Акционеры

Название Доля (%)
Freefloat93,04
Capital Research & Management Co. (Global Investors)11,01
Capital Research & Management Co. (International Investors)10,40
Vanguard Group, Inc. (Subfiler)8,58
American Funds Growth Fund Of America7,99
The Vanguard Group, Inc.7,98
T. Rowe Price Associates, Inc. (Investment Management)7,72
American Funds New Perspective Fund6,49
Wellington Management Co. LLP5,64
Emil D. Kakkis, MD, PhD5,25
Federated Global Investment Management Corp.4,94
BlackRock Fund Advisors4,21
Capital Research & Management Co. (World Investors)4,11
State Street Corp.3,66
Fidelity Management & Research Co. LLC3,61

Адрес

а/я:
Телефон:
Факс:
Вэб:

Менеджмент

Добавить или редактировать инструмент